STO-609, a specific inhibitor of the CA2+/calmodulin-dependent protein kinase kinase

Hiroshi Tokumitsu, Hiroyuki Inuzuka, Yumi Ishikawa, Masahiko Ikeda, Ikutaro Saji, Ryoji Kobayashi

Research output: Contribution to journalArticle

198 Citations (Scopus)

Abstract

STO-609, a selective inhibitor of Ca2+/calmodulin-dependent protein kinase kinase (CaM-KK) was synthesized, and its inhibitory properties were investigated both in vitro and in vivo. STO-609 inhibits the activities of recombinant CaM-KKα and CaM-KKβ isoforms, with Ki values of 80 and 15 ng/ml, respectively, and also inhibits their autophosphorylation activities. Comparison of the inhibitory potency of the compound against various protein kinases revealed that STO-609 is highly selective for CaM-KK without any significant effect on the downstream CaM kinases (CaM-KI and -IV), and the IC50 value of the compound against CaM-KII is ∼10 μg/ ml. STO-609 inhibits constitutively active CaM-KKα (glutathione S-transferase (GST)-CaM-KK-(84-434)) as well as the wild-type enzyme. Kinetic analysis indicates that the compound is a competitive inhibitor of ATP. In transfected HeLa cells, STO-609 suppresses the Ca2+-induced activation of CaM-KIV in a dose-dependent manner. In agreement with this observation, the inhibitor significantly reduces the endogenous activity of CaM-KK in SH-SY5Y neuroblastoma cells at a concentration of 1 μg/ml (∼80% inhibitory rate). Taken together, these results indicate that STO-609 is a selective and cell-permeable inhibitor of CaM-KK and that it may be a useful tool for evaluating the physiological significance of the CaM-KK-mediated pathway in vivo as well as in vitro.

Original languageEnglish
Pages (from-to)15813-15818
Number of pages6
JournalJournal of Biological Chemistry
Volume277
Issue number18
DOIs
Publication statusPublished - May 3 2002
Externally publishedYes

Fingerprint

Calcium-Calmodulin-Dependent Protein Kinases
Phosphotransferases
Calcium-Calmodulin-Dependent Protein Kinase Type 4
STO 609
Calcium-Calmodulin-Dependent Protein Kinase Type 2
Glutathione Transferase
Neuroblastoma
HeLa Cells
Protein Kinases
Inhibitory Concentration 50
Protein Isoforms
Adenosine Triphosphate
Chemical activation
Kinetics

ASJC Scopus subject areas

  • Biochemistry

Cite this

STO-609, a specific inhibitor of the CA2+/calmodulin-dependent protein kinase kinase. / Tokumitsu, Hiroshi; Inuzuka, Hiroyuki; Ishikawa, Yumi; Ikeda, Masahiko; Saji, Ikutaro; Kobayashi, Ryoji.

In: Journal of Biological Chemistry, Vol. 277, No. 18, 03.05.2002, p. 15813-15818.

Research output: Contribution to journalArticle

Tokumitsu, Hiroshi ; Inuzuka, Hiroyuki ; Ishikawa, Yumi ; Ikeda, Masahiko ; Saji, Ikutaro ; Kobayashi, Ryoji. / STO-609, a specific inhibitor of the CA2+/calmodulin-dependent protein kinase kinase. In: Journal of Biological Chemistry. 2002 ; Vol. 277, No. 18. pp. 15813-15818.
@article{589c568e1ac44f9c9c5911b7196d668e,
title = "STO-609, a specific inhibitor of the CA2+/calmodulin-dependent protein kinase kinase",
abstract = "STO-609, a selective inhibitor of Ca2+/calmodulin-dependent protein kinase kinase (CaM-KK) was synthesized, and its inhibitory properties were investigated both in vitro and in vivo. STO-609 inhibits the activities of recombinant CaM-KKα and CaM-KKβ isoforms, with Ki values of 80 and 15 ng/ml, respectively, and also inhibits their autophosphorylation activities. Comparison of the inhibitory potency of the compound against various protein kinases revealed that STO-609 is highly selective for CaM-KK without any significant effect on the downstream CaM kinases (CaM-KI and -IV), and the IC50 value of the compound against CaM-KII is ∼10 μg/ ml. STO-609 inhibits constitutively active CaM-KKα (glutathione S-transferase (GST)-CaM-KK-(84-434)) as well as the wild-type enzyme. Kinetic analysis indicates that the compound is a competitive inhibitor of ATP. In transfected HeLa cells, STO-609 suppresses the Ca2+-induced activation of CaM-KIV in a dose-dependent manner. In agreement with this observation, the inhibitor significantly reduces the endogenous activity of CaM-KK in SH-SY5Y neuroblastoma cells at a concentration of 1 μg/ml (∼80{\%} inhibitory rate). Taken together, these results indicate that STO-609 is a selective and cell-permeable inhibitor of CaM-KK and that it may be a useful tool for evaluating the physiological significance of the CaM-KK-mediated pathway in vivo as well as in vitro.",
author = "Hiroshi Tokumitsu and Hiroyuki Inuzuka and Yumi Ishikawa and Masahiko Ikeda and Ikutaro Saji and Ryoji Kobayashi",
year = "2002",
month = "5",
day = "3",
doi = "10.1074/jbc.M201075200",
language = "English",
volume = "277",
pages = "15813--15818",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "18",

}

TY - JOUR

T1 - STO-609, a specific inhibitor of the CA2+/calmodulin-dependent protein kinase kinase

AU - Tokumitsu, Hiroshi

AU - Inuzuka, Hiroyuki

AU - Ishikawa, Yumi

AU - Ikeda, Masahiko

AU - Saji, Ikutaro

AU - Kobayashi, Ryoji

PY - 2002/5/3

Y1 - 2002/5/3

N2 - STO-609, a selective inhibitor of Ca2+/calmodulin-dependent protein kinase kinase (CaM-KK) was synthesized, and its inhibitory properties were investigated both in vitro and in vivo. STO-609 inhibits the activities of recombinant CaM-KKα and CaM-KKβ isoforms, with Ki values of 80 and 15 ng/ml, respectively, and also inhibits their autophosphorylation activities. Comparison of the inhibitory potency of the compound against various protein kinases revealed that STO-609 is highly selective for CaM-KK without any significant effect on the downstream CaM kinases (CaM-KI and -IV), and the IC50 value of the compound against CaM-KII is ∼10 μg/ ml. STO-609 inhibits constitutively active CaM-KKα (glutathione S-transferase (GST)-CaM-KK-(84-434)) as well as the wild-type enzyme. Kinetic analysis indicates that the compound is a competitive inhibitor of ATP. In transfected HeLa cells, STO-609 suppresses the Ca2+-induced activation of CaM-KIV in a dose-dependent manner. In agreement with this observation, the inhibitor significantly reduces the endogenous activity of CaM-KK in SH-SY5Y neuroblastoma cells at a concentration of 1 μg/ml (∼80% inhibitory rate). Taken together, these results indicate that STO-609 is a selective and cell-permeable inhibitor of CaM-KK and that it may be a useful tool for evaluating the physiological significance of the CaM-KK-mediated pathway in vivo as well as in vitro.

AB - STO-609, a selective inhibitor of Ca2+/calmodulin-dependent protein kinase kinase (CaM-KK) was synthesized, and its inhibitory properties were investigated both in vitro and in vivo. STO-609 inhibits the activities of recombinant CaM-KKα and CaM-KKβ isoforms, with Ki values of 80 and 15 ng/ml, respectively, and also inhibits their autophosphorylation activities. Comparison of the inhibitory potency of the compound against various protein kinases revealed that STO-609 is highly selective for CaM-KK without any significant effect on the downstream CaM kinases (CaM-KI and -IV), and the IC50 value of the compound against CaM-KII is ∼10 μg/ ml. STO-609 inhibits constitutively active CaM-KKα (glutathione S-transferase (GST)-CaM-KK-(84-434)) as well as the wild-type enzyme. Kinetic analysis indicates that the compound is a competitive inhibitor of ATP. In transfected HeLa cells, STO-609 suppresses the Ca2+-induced activation of CaM-KIV in a dose-dependent manner. In agreement with this observation, the inhibitor significantly reduces the endogenous activity of CaM-KK in SH-SY5Y neuroblastoma cells at a concentration of 1 μg/ml (∼80% inhibitory rate). Taken together, these results indicate that STO-609 is a selective and cell-permeable inhibitor of CaM-KK and that it may be a useful tool for evaluating the physiological significance of the CaM-KK-mediated pathway in vivo as well as in vitro.

UR - http://www.scopus.com/inward/record.url?scp=0037013222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037013222&partnerID=8YFLogxK

U2 - 10.1074/jbc.M201075200

DO - 10.1074/jbc.M201075200

M3 - Article

VL - 277

SP - 15813

EP - 15818

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 18

ER -